We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In this article, we are going ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

Leerink Partners analyst Andrew Berens has maintained their bullish stance on MRUS stock, giving a Buy rating yesterday.Pick the best stocks ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Merus (MRUS – Research Report) yesterday and set a price target of ...

Merus (NASDAQ:MRUS – Get Free Report) had its price target hoisted by research analysts at Citigroup from $89.00 to $97.00 in ...

Needham & Company LLC reaffirmed their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $85.00 price target on the ...

December 05, 2024, 04:52 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...

Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or ...

Merus partners with Partner Therapeutics for U.S. rights to Zeno in NRG1+ cancer. Updated petosemtamab data emerge as a key ...

Percentages: FG .431, FT .625. 3-Point Goals: 8-26, .308 (Rose 2-4, Payne 2-6, Mrus 2-7, Brickner 1-1, Mitchell 1-3, Anderson 0-1, Gonzalez 0-1, Linhardt 0-1, Yearout 0-2).

Get real-time COLLEGEBASKETBALL basketball coverage and scores as Idaho Vandals takes on Oregon State Beavers. We bring you the latest game previews, live stats, and recaps on CBSSports.com ...

In this article, we are going to take a look at where Merus NV (NASDAQ:MRUS) stands against the other promising cancer stocks. According to the World Health Organization (WHO), cancer remains one ...